TY - JOUR
T1 - Convergence of progesterone with growth factor and cytokine signaling in breast cancer
T2 - Progesterone receptors regulate signal transducers and activators of transcription expression and activity
AU - Richer, Jennifer K.
AU - Lange, Carol A.
AU - Manning, Nicole G.
AU - Owen, Gareth
AU - Powell, Roger
AU - Horwitz, Kathryn B.
PY - 1998/11/20
Y1 - 1998/11/20
N2 - STATS (signal transducers and activators of transcription) are latent transcription factors activated in the cytoplasm by diverse cell surface signaling molecules. Like progesterone receptors (PR), Stat5a and 5b are required for normal mammary gland growth and differentiation. These two proteins are up-regulated during pregnancy, a period dominated by high levels of progesterone. We now show that progestin treatment of breast cancer cells regulates Stat5a and 5b, Stat3, and Stat1 protein levels in a PR-dependent manner. In addition, progestin treatment induces translocation of Stat5 into the nucleus, possibly mediated by the association of PR and Stat5. Last, progesterone pretreatment enhances the phosphorylation of Stat5 on tyrosine 694 induced by epidermal growth factor. Functional data show that progestin pretreatment of breast cancer cells enhances the ability of prolactin to stimulate the transcriptional activity of Stat5 on a β-casein promoter. Progesterone and epidermal growth factor synergize to control transcription from p21(WAF1) and c-fos promoters. These data demonstrate the convergence of progesterone and growth factor/cytokine signaling pathways at multiple levels, and suggest a mechanism for coordination of PR and Stat5-mediated proliferative and differentiative events in the mammary gland.
AB - STATS (signal transducers and activators of transcription) are latent transcription factors activated in the cytoplasm by diverse cell surface signaling molecules. Like progesterone receptors (PR), Stat5a and 5b are required for normal mammary gland growth and differentiation. These two proteins are up-regulated during pregnancy, a period dominated by high levels of progesterone. We now show that progestin treatment of breast cancer cells regulates Stat5a and 5b, Stat3, and Stat1 protein levels in a PR-dependent manner. In addition, progestin treatment induces translocation of Stat5 into the nucleus, possibly mediated by the association of PR and Stat5. Last, progesterone pretreatment enhances the phosphorylation of Stat5 on tyrosine 694 induced by epidermal growth factor. Functional data show that progestin pretreatment of breast cancer cells enhances the ability of prolactin to stimulate the transcriptional activity of Stat5 on a β-casein promoter. Progesterone and epidermal growth factor synergize to control transcription from p21(WAF1) and c-fos promoters. These data demonstrate the convergence of progesterone and growth factor/cytokine signaling pathways at multiple levels, and suggest a mechanism for coordination of PR and Stat5-mediated proliferative and differentiative events in the mammary gland.
UR - http://www.scopus.com/inward/record.url?scp=0032553553&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0032553553&partnerID=8YFLogxK
U2 - 10.1074/jbc.273.47.31317
DO - 10.1074/jbc.273.47.31317
M3 - Article
C2 - 9813040
AN - SCOPUS:0032553553
SN - 0021-9258
VL - 273
SP - 31317
EP - 31326
JO - Journal of Biological Chemistry
JF - Journal of Biological Chemistry
IS - 47
ER -